Home » Topics » BioWorld Science

BioWorld Science
RSS

Innovent initiates phase I/II studies of IBI-318

Dec. 17, 2020

Kineta initiates phase I trial of KCP-506 for chronic neuropathic pain

Dec. 16, 2020

Nascent cleared by FDA to begin phase I trial of pritumumab for brain cancer

Dec. 16, 2020

Clinical benefit seen with SOR-007 in patients with cutaneous metastases

Dec. 16, 2020

Valneva opens phase I/II study of COVID-19 vaccine candidate VLA-2001

Dec. 16, 2020

Glutamate "plumes" identified in spreading depression, migraine

Dec. 16, 2020

Low-dose cohort data reported from phase I/II study of AXO-AAV-GM1 for GM1 gangliosidosis

Dec. 16, 2020

Phase IIb/III study of oral masitinib in Alzheimer's disease meets primary endpoint

Dec. 16, 2020

PRDM2, a novel SMAD3-dependent immunosuppressor for promoting NSCLC

Dec. 16, 2020

Duke University presents new pro-N-cadherin-targeting humanized antibodies

Dec. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...